Catalyst Pharma's LEMS drug Firdapse wins FDA nod, as regulators keep the approval engine running at record speed
Turns out, a web error by a company contractor that tipped off investors Catalyst Pharmaceuticals’ $CPRX Firdapse had won approval earlier in the week offered …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
